Related Experiment Video
Updated: Feb 4, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy.
1Department of Cardiology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
This review explores the roles of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in heart function and disease. These non-coding RNAs are key players in cardiac gene expression and remodeling, offering potential therapeutic targets for cardiomyopathies.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Genomics
Background:
- Protein-coding genes are crucial for heart development and function, with mutations linked to cardiovascular disease.
- The majority of the human genome is non-coding, producing various non-coding RNAs (ncRNAs).
- MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are key classes of ncRNAs with emerging roles in cardiac biology.
Purpose of the Study:
- To review and discuss the function and molecular mechanisms of miRNAs and lncRNAs in the heart.
- To focus on the involvement of these ncRNAs in both ischemic and non-ischemic cardiomyopathy.
- To highlight the therapeutic potential of ncRNAs in cardiovascular diseases.
Main Methods:
- Literature review of recent studies on ncRNAs in cardiac function and disease.
- Analysis of molecular mechanisms underlying miRNA and lncRNA action in cardiomyocytes.
- Synthesis of findings related to ncRNA roles in cardiac remodeling and stress response.
Main Results:
- Emerging evidence shows miRNAs and lncRNAs regulate cardiac gene expression, cardiomyocyte proliferation, and differentiation.
- These ncRNAs are implicated in cardiac remodeling processes in response to stress.
- Specific functions of miRNAs and lncRNAs have been identified in both ischemic and non-ischemic cardiomyopathy.
Conclusions:
- Non-coding RNAs, including miRNAs and lncRNAs, are integral to cardiac gene regulation and function.
- Dysregulation of these molecules contributes to the pathogenesis of cardiomyopathy.
- Non-coding RNAs represent promising future therapeutic targets for cardiovascular diseases.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
lncRNA - Long Non-coding RNAs
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
RNA Splicing

